Loading...

Livzon Pharmaceutical Group Inc.

1513.HKHKSE
HealthcareDrug Manufacturers - Specialty & Generic
HK$29.85
HK$0.70(2.40%)

Livzon Pharmaceutical Group Inc. (1513.HK) AI-Powered Stock Analysis

See how Livzon Pharmaceutical Group Inc. scores across key metrics like financial growth, valuation, and market position using AI-driven evaluation.

Model Information

The AI Stock Analysis Model is provided for informational purposes only and should not be considered financial advice. We are continously improving this model to increase accuracy and performance.Read our Full Disclaimer

Livzon Pharmaceutical Group Inc. (1513.HK) Stock Overall Grade

Livzon Pharmaceutical Group Inc.’s grade based on a comprehensive AI analysis of financial metrics, growth potential, and market position.

B+

Good

Grade Breakdown by Metric

See how each financial and market factor contributes to Livzon Pharmaceutical Group Inc.'s overall stock rating.

Forecast

A

Score

80/100

Financial Growth

A+

Score

95/100

Fundamental Growth

B+

Score

78/100

Key Ratios

A

Score

86/100

Sector Comparison

B+

Score

75/100

Industry Comparison

B+

Score

75/100

S&P 500 Benchmark

A

Score

85/100

Analyst Consensus

C+

Score

50/100

Component Analysis Explained

Understand the key factors behind each Livzon Pharmaceutical Group Inc. stock grade, including financials, comparisons, and forecasts.

Frequently Asked Questions